Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta
Clinical trial NCT06636071 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06636071
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-25
- Primary completion
- 2027-01-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.